Major R01 grant from NCI for translational and clinical research

Awarded to Theodore Lawrence, MD, PhD, FASTRO, FASCO, and Mukesh Nyati, PhD, for “Development of a first-in-class mEGFR dimerization inhibitor"

Theodore Lawrence, MD, PhD (left) and Mukesh Nyati, PhD (right)

Multi-PI, inter-programmatic, $2.1M R01 awarded by the National Cancer Institute (NCI) to Theodore Lawrence, MD, PhD, FASTRO, FASCO, and Mukesh Nyati, PhD, for “Development of a first-in-class mEGFR dimerization inhibitor"

Theodore S Lawrence laboratory

Mukesh Nyati laboratory